The genetic basis for inactivation of Wnt pathway in human osteosarcoma

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Du, Xiaoling ^a   Yang, Jilong ^a,b   Yang, Da ^b   Tian, Wei ^a   Zhu, Ze ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Genetic aberration; Microarray based comparative genomic hybridization; Osteosarcoma; Wnt signal pathway

Indexed keywords

BETA CATENIN; CYCLIN D1; MESSENGER RNA; MYC PROTEIN; WNT1 PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOPLASM; DISEASE FREE SURVIVAL; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE INACTIVATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; OSTEOSARCOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA SEQUENCE; SURVIVAL TIME; TRANSCRIPTOMICS; WNT SIGNALING PATHWAY; BONE NEOPLASMS; CANCER STAGING; CHILD; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; YOUNG ADULT;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OSTEOSARCOMA; WNT SIGNALING PATHWAY; YOUNG ADULT;

EID: 84902301325     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-450     Document Type: Article

References (26)

1. Picci P, Mercuri M, Ferrari S, Alberghini M, Briccoli A, Ferrari C, Pignotti E, Bacci G. Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol 2010, 21(6):1366-1373.
2. Yang J, Yang D, Sun Y, Sun B, Wang G, Trent JC, Araujo DM, Chen K, Zhang W. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Cancer 2011, 117(21):4925-4938.
3. Yang J, Cogdell D, Yang D, Hu L, Li H, Zheng H, Du X, Pang Y, Trent J, Chen K, Zhang W. Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma. Cancer Lett 2010, 291(1):31-38.
4. Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer 2004, 4(5):335-348.
5. Thomas DM. Wnts, bone and cancer. J Pathol 2010, 220(1):1-4.
6. Iwaya K, Ogawa H, Kuroda M, Izumi M, Ishida T, Mukai K. Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis. Clin Exp Metastasis 2003, 20(6):525-529.
7. Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons PJ, Dawid IB, Thomas DM. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J Clin Invest 2009, 119(4):837-851.
8. Cai Y, Mohseny AB, Karperien M, Hogendoorn PC, Zhou G, Cleton-Jansen AM. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. J Pathol 2010, 220(1):24-33.
9. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992, 10(1):5-15.
10. Boussen H, Mezzi F, Gamoudi A, Daldoul O, Ben Hamida H, Mezlini A, Khalfallah S, Karray S, Ben Romdhane K, Ben Ghachem M, Ben Abdallah M, Douik M, Saadi A, Ben Ayed F, Ben Hassine H. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases]. Bull Cancer 2000, 87(2):183-188.
11. Squire JA, Pei J, Marrano P, Beheshti B, Bayani J, Lim G, Moldovan L, Zielenska M. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chromosomes Cancer 2003, 38(3):215-225.
12. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004, 5(4):557-572.
13. Van Wieringen WN, Van De Wiel MA, Ylstra B. Weighted clustering of called array CGH data. Biostatistics 2008, 9(3):484-500.
14. Kresse SH, Ohnstad HO, Paulsen EB, Bjerkehagen B, Szuhai K, Serra M, Schaefer KL, Myklebost O, Meza-Zepeda LA. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes Chromosomes Cancer 2009, 48(8):679-693.
15. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013, 14(4):R36.
16. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008, 5(7):621-628.
17. Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL, Moon RT. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci U S A 2009, 106(4):1193-1198.
18. De Blasio A, Messina C, Santulli A, Mangano V, Di Leonardo E, D'Anneo A, Tesoriere G, Vento R. Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells. FEBS Lett 2005, 579(3):615-620.
19. Gazitt Y, Kolaparthi V, Moncada K, Thomas C, Freeman J. Targeted therapy of human osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways. Int J Oncol 2009, 34(2):551-561.
20. Takayama S, Rogatsky I, Schwarcz LE, Darimont BD. The glucocorticoid receptor represses cyclin D1 by targeting the Tcf-beta-catenin complex. J Biol Chem 2006, 281(26):17856-17863.
21. Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA, Singer S, Maki RG, Cordon-Cardo C. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 2007, 117(11):3248-3257.
22. Gu Y, Pan Y, Meng B, Guan B, Fu K, Sun B, Zheng F. High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma. Tumour Biol 2013, 34(3):1441-1450.
23. Liang S, Mu K, Wang Y, Zhou Z, Zhang J, Sheng Y, Zhang T. CyclinD1, a prominent prognostic marker for endometrial diseases. Diagn Pathol 2013, 8:138.
24. Gregory CA, Singh H, Perry AS, Prockop DJ. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 2003, 278(30):28067-28078.
25. Daino K, Ugolin N, Altmeyer-Morel S, Guilly MN, Chevillard S. Gene expression profiling of alpha-radiation-induced rat osteosarcomas: identification of dysregulated genes involved in radiation-induced tumorigenesis of bone. Int J Cancer 2009, 125(3):612-620.
26. Leow PCTQ, Ong ZY, Yang Z, Ee PL. Antitumor activity of natural compounds, curcumin and p KF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells. Invest New Drugs 2010, 28(6):766-782.